人表皮生长因子受体2-话题@MedSci

#人表皮生长因子受体2#

3篇内容 | 1007人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2209106, encodeId=3f12220910618, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生长因子受体2#</a>, objectTitle=European Radiology：人表皮生长因子受体2低表达与过表达的乳腺癌亚型MRI鉴别, objectType=article, longId=829511, objectId=ccfd82951170, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240604/1717488133490_5579292.png, objectUrl=/article/show_article.do?id=ccfd82951170, replyNumber=0, likeNumber=106, createdTime=2024-06-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ccfd82951170, moduleTitle=European Radiology：人表皮生长因子受体2低表达与过表达的乳腺癌亚型MRI鉴别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccfd82951170)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1763361, encodeId=3b031e6336145, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生长因子受体2#</a>, objectTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, objectType=article, longId=195901, objectId=b90719590192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b90719590192, replyNumber=0, likeNumber=86, createdTime=2020-12-09, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b90719590192, moduleTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b90719590192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763360, encodeId=c8801e633607f, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生长因子受体2#</a>, objectTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, objectType=article, longId=195894, objectId=347c195894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347c195894a4, replyNumber=0, likeNumber=75, createdTime=2021-03-29, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347c195894a4, moduleTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=347c195894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763359, encodeId=79781e633594b, content=<a href='/topic/show?id=75b12516efe' target=_blank style='color:#2F92EE;'>#人表皮生长因子受体2#</a>, objectTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, objectType=article, longId=159143, objectId=231c15914303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231c15914303, replyNumber=0, likeNumber=61, createdTime=2019-04-18, rootId=0, userName=ms7517674339485982, userId=2c3037501783, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231c15914303, moduleTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231c15914303)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

人表皮生长因子受体2

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#乳腺癌# #人表皮生长因子受体2#

European Radiology：人表皮生长因子受体2低表达与过表达的乳腺癌亚型MRI鉴别

2024-06-09发表于上海

ms7517674339485982 (审核中...)

前往app查看评论内容

#人表皮生长因子受体2#

J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析

2020-12-09

ms7517674339485982 (审核中...)

前往app查看评论内容

#人表皮生长因子受体2#

Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果

2021-03-29

ms7517674339485982 (审核中...)

前往app查看评论内容

#人表皮生长因子受体2#

2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析

2019-04-18

科室
- - 订阅+
  - 更多科室
工具
服务